baber/WOPTO huggingface dataset:
Patent JP-2790151-B2 (JP)
IPC: G09F13/16
Filed: 1991-11-07
Granted: 1998-08-27
Abstract: A display has a transparent plastic substrate and a colored image formed on the substrate. The colored image is formed on the substrate by process printing a large number of small dots, colored red, yellow, and blue, in a predetermined pattern onto the substrate. The red, yellow, and blue ink dots are translucent to visible light. A reflective layer is deposited against the ink layer to reflect light which passes through the ink layer and thereby give the image formed by the ink layer a shiny, metallic appearance. A stratum of opaque white ink is deposited between the reflective layer and preselected portions of the image to block the passage of visible light from the preselected portions to the reflective layer.
Patent JP-H0552821-B2 (JP)
Inventor: YUUSEFUSON BYOON
IPC: C07C239/00
Filed: 1987-05-18
Abstract: A new chiral reagent of formula (I), wherein X is halogen, an azide group or a succinimidyl group and wherein R is an alkyl group or a trifluormethyl group. The invention further relates to a method for derivatization, determination and preparative resolution of primary and secondary amino-containing compounds. The method comprises the steps of derivatizing the amino function by said reagent to form diastereomeric carbamates, which are determined by e.g. fluorimetry or absorptiometry after separation by liquid chromatography.
Patent JP-3726841-B2 (JP)
IPC: C12N7/01
Filed: 1995-06-23
Granted: 2005-12-14
Abstract: A method for killing malignant brain tumor cells in vivo entails providing replication competent herpes simplex virus vectors to tumor cells. A replication competent herpes simplex virus vector, with defective expression of the  gamma 34.5 gene and the ribonucleotide reductase gene, specifically destroys tumor cells, is hypersensitive to anti-viral agents, and yet is not neurovirulent.
Patent JP-2760793-B2 (JP)
IPC: A61L27/12
Filed: 1987-06-05
Granted: 1998-06-04
Abstract: Biocompatible particles and an article incorporating a plurality of such particles is disclosed. The particles can have means for interconnecting such as an aperture for stringing the particles on a filament or interlocking external shape. A plurality of particles, with or without means for interconnecting, can be fashioned into an article by interconnecting the particles with a flexible material. When the particles have a means for interconnecting, the plurality of particles can also be interconnected by a rigid material. The particles or plurality of interconnected particles are useful for medical, dental or veterinary or biotechnical applications, such as bone, tooth or skin implants, including alveolar ridge augmentation, or as a growth substrate material. Any biocompatible material can be used, including ceramics such a hydroxylapatite.
Patent JP-3078330-B2 (JP)
IPC: H04B/
Filed: 1995-07-05
Granted: 2000-08-21
Abstract: The power control process of the present invention enables a base station communicating over a forward packet channel to a mobile radio to control the power of the mobile radio transmitting over a reverse packet channel to the base station. The base station maintains a maximum energy per bit to total interference spectral density ratio threshold for the reverse channel as well as a desired threshold that results in a low frame error rate. By comparing each radiotelephone's estimated energy per bit to total interference spectral density ratio to the desired and maximum thresholds, power control commands to increase or decrease the radiotelephone's transmit power are generated depending on the outcome of the comparison. <IMAGE>
Patent JP-2933337-B2 (JP)
IPC: A61M37/00
Filed: 1989-06-13
Granted: 1999-08-09
Abstract: Subsaturated, rate controlled delivery devices (1) for delivering an agent (5). The initial equilibrated concentration of the agent in the agent reservoir (3) and the adhesive (5) is below saturation. The initial loading of the agent in reservoir (3) is sufficient to prevent the activity of the agent in the reservoir (3) from decreasing by more than about 75 % and preferably no more than about 25 % during the predetermined period of administration. The thicknesses of the adhesive (5), rate controlling membrane (4) and reservoir (3) layers are selected so that at least 50 % and, preferably at least 75 % of the initial equilibrated agent loading is in the reservoir layer (3). The devices (1) are usable to deliver agents which are liquid at body temperatures such as benzotropine, secoverine, nicotine, arecoline, polyethylene glycol monolaurate, glycerol monolaurate, glycerol monooleate and ethanol, for example.
Patent JP-2997548-B2 (JP)
IPC: D03D1/02
Filed: 1995-08-15
Granted: 2000-01-11
Abstract: PCT No. PCT/CH95/00180 Sec. 371 Date Feb. 6, 1997 Sec. 102(e) Date Feb. 6, 1997 PCT Filed Aug. 15, 1995 PCT Pub. No. WO96/05985 PCT Pub. Date Feb. 29, 1996An uncoated fabric with linen or ripstop binding of a polyamide filament yarn with a fibril titer of 1.5 to 7 dtex, a strength of 50 to 80 cN/tex and an elongation of 15 to 30%, for producing an impact gas bag (airbag), characterized in that the fabric simultaneously has an air permeability of <1/dm2/min, a residual boiling shrinkage of <2%, and a tear propagation strength in warp and weft of >110 N.
Patent JP-3138980-B2 (JP)
IPC: H01M4/74
Filed: 1993-10-04
Granted: 2001-02-26
Abstract: The strip is cast on a chilled casting surface of a rotating drum from a pool of the molten metal contained in a tundish having a graphite lip insert seated therein cooperating with, the casting surface adjacent to the tundish to form and contain the pool of the molten metal. The tundish preferably contains a feed chamber, a return chamber, and a diverting chamber, the feed chamber and the diverting chamber effectively removing turbulence from the molten feed and the return chamber having a vertically adjustable weir dividing the return chamber from the diverting chamber for controlling the surface level of the pool of molten metal in the diverting chamber and the lip insert and for diverting a flow of molten metal to the return chamber. A preferred lead alloy is a low antimony-lead alloy which is cast into strip and is subjected to a heat treatment to permit expansion and shaping in subsequent production of expanded mesh battery grids. The battery grids produced by the method have improved electrochemical properties such as corrosion resistance and resistance to growth.
Patent JP-3507080-B2 (JP)
IPC: H04H20/82
Filed: 1996-07-25
Granted: 2004-03-15
Abstract: A method and apparatus for carrying out synchronous co-division multiple access (SCDMA) communication of multiple channels of digital data over a shared transmission media (1162). The system includes modems at remote units (1164) and a central unit (1160) to receive time division multiplexed digital data arranged into timeslots or channels and uses orthogonal codes to encode each channel of multiple data and spread the energy of each channel data over a frame of data transmitted in a code domain. Frames are synchronized as between remote (1164) and central units (1160) using a ranging scheme which is also useful in any other system transmitting data by frames in a distributed system where synchronizing the frames as between all units regardless of differences in propagation delays is necessary. Each frame in the SCDMA modulation scheme includes a gap or guardband containing no other data.
Patent JP-3396484-B2 (JP)
IPC: C07D495/04
Filed: 1996-08-26
Granted: 2003-04-14
Abstract: This invention is concerned with an improved process for the synthesis of hydroxysulfone, which is a key intermediate in the synthesis of carbonic anhydrase inhibitors, especially dorzolamide. Carbonic anhydrase inhibitors are known to be effective in treating elevated intraocular pressure or glaucoma.
Patent JP-3407073-B2 (JP)
IPC: C09J7/00
Filed: 1993-10-27
Granted: 2003-05-19
Abstract: PCT No. PCT/EP93/02970 Sec. 371 Date Jul. 12, 1995 Sec. 102(e) Date Jul. 12, 1995 PCT Filed Oct. 27, 1993 PCT Pub. No. WO94/10999 PCT Pub. Date May 26, 1994A transdermal therapeutic system for the administration of physostigmine to the skin, consisting of a backing layer impermeable to active substance, a pressure-sensitive reservoir layer containing 40 to 90%-wt. polymeric material and 0.1 to 20%-wt. physostigmine base or one of the pharmaceutically acceptable salts thereof, and of a detachable protective layer covering the reservoir layer, comprises in its reservoir layer acrylate- and/or methacrylate-based polymeric material and 0.1 to 40%-wt. of a softener containing the hydroxyl group with an HLB value between 1.1 and 12.0.
Patent JP-3043803-B2 (JP)
IPC: C12P21/02
Filed: 1990-08-28
Granted: 2000-05-22
Abstract: Fusion proteins are obtained in high yields if a mixed oligonucleotide is constructed which codes for the ballast constituent of the fusion protein. The oligonucleotide mixture is introduced in a vector in such a manner that it is functionally linked to a regulatory region and to the structural gene for the desired protein. Appropriate host cells are transformed with the plasmid population obtained in this manner and the clones producing a high yield of coded fusion protein are selected.
Patent JP-2902782-B2 (JP)
IPC: E01C9/04
Filed: 1991-07-31
Granted: 1999-06-07
Abstract: In the region of the track (2) the roadway is formed by inner (3) and outer (4) roadway plates whereby the inner plates (3) are self-supporting and bridge the distance between the rails (5) of the track (2) and have at their edges bordering the track projecting bearing ribs (7) by which the inner plates (3) are supported on the rail bases (10), laterally against the rail web (11) and at the top against the rail heads (12) with the insertion of elastic, shaped supports (8, 9) of rubber or plastic whereby lower supporting components (8) with an angular cross-section are provided to locate the bearing ribs (7) of the inner plates (3) on the rails (2) which bear on the rail base via one shank (18) while the other shank (20) is beside the rail web (11). The top (28) of the shank (18) of the angular cross-section lower support (8) lying on the rail base (10) and the base (23) of the bearing ribs (7) supported thereon run approximately parallel to the top (29) of the rail base. A plurality of adjacent grooves (31) is provided at least on the bottom (30) of the shank (18) of the lower support (8) lying on the rail base (10) and preferably also on the other surfaces facing the rails (2).
Patent JP-2989007-B2 (JP)
IPC: C07K1/12
Filed: 1991-06-21
Granted: 1999-12-13
Abstract: A method of forming an amino acid thiohydantoin from an N-protected amino acid or the C-terminal amino acid of an N-protected peptide. The amino acid is activated by reaction with a ketenimine, and the activated ester is converted to the thiohydantoin by reaction with silyl or pyridine isothiocyanate. The ketenimine is generated by treating an N-substituted isoxazolium compound, such as Woodwards Reagent K with a base, preferably in the presence of the amino acid. Also disclosed is a solid phase support having a derivatized N-substituted isoxazolium or ketenimine group for use in the method.
Patent JP-3378256-B2 (JP)
IPC: C08L3/02
Filed: 1997-09-10
Granted: 2003-02-17
Abstract: PCT No. PCT/US97/15973 Sec. 371 Date Mar. 11, 1999 Sec. 102(e) Date Mar. 11, 1999 PCT Filed Sep. 10, 1997 PCT Pub. No. WO98/10861 PCT Pub. Date Mar. 19, 1998The present invention relates to microporous starch granules surface coated with a hydrophobic agent said granules useful in absorbing hydrophobic malodorous materials either from the liquid or gas phase. The hydrophobic granules are useful in controlling the malodors associated with catmenials and hygienic undergarments as well as being useful for absorbing unwanted food and other environmental malodors.
Patent JP-H0776302-B2 (JP)
IPC: B29C48/09
Filed: 1990-10-04
Abstract: I. Polymer blend composition having improved processibility and comprising: 1) a difficultly-melt-processible polymer and 0.002 - 0.5 wt. % of one more fluoropolymer process aids wherein the fluoropolymer has a fluorine to carbon ratio of at least 1:2, is capable of forming a die-coating film under the prevailing conditions of extrusion temperature and pressure, and contains an effective amount of polar functional polymer chain end groups, -W, wherein -W is selected from -COF, -SO3M, -OSO3M and -COOM, wherein M is hydrogen, a metal cation, preferably an alkali or alkaline earth metal cation, or a quaternary ammonium cation; or 2) (a) a major portion of a difficultly melt-processible polymer and (b) a minor portion of: (1) at least an effective amount, to improve processibility, of a fluorocarbon copolymer which at the melt-processing temperature of (a) is either in a melted form if crystalline, or is above its glass transition temperature if amorphous, and (2) at least an effective amount, to improve processibility, of at least one tetrafluoroethylene homopolymer or copolymer of tetrafluoroethylene and at least one monomer copolymerizable therewith, wherein the mole ratio of fluorine to hydrogen is at least 1:1, and which is solid at the melt-processing temperature of (a); II. masterbatches comprised of a processing aid; and III. processes utilizing a processing aid.
Patent JP-3159983-B2 (JP)
IPC: C08B37/08
Filed: 1991-11-04
Granted: 2001-04-23
Abstract: PCT No. PCT/GB91/01927 Sec. 371 Date Jul. 6, 1993 Sec. 102(e) Date Jul. 6, 1993 PCT Filed Nov. 4, 1991 PCT Pub. No. WO92/08799 PCT Pub. Date May 29, 1992.A process for the production of hyaluronic acid by continuous fermentation of Streptococcus equi in a chemostat culture gives high yields of high molecular weight hyaluronic acid uncontaminated by toxic impurities. The process is advantageous in that it solves the problem of traditional batch culture in which degradation enzymes can begin to break down the cell walls of Streptococcus releasing cell contents into the fermenter broth, leading to purification difficulties.
Patent JP-4798814-B2 (JP)
IPC: A61P3/04
Filed: 1998-01-07
Granted: 2011-10-19
Abstract: A pharmaceutical composition comprising an exendin or an exendin agonist peptide and a buffer, wherein said composition has a pH of from 3.0 to 8.0, provided that the composition is not suspended in an aqueous buffer at a pH of about 5.6 to 7.4.
Patent JP-3923523-B2 (JP)
IPC: B65B21/02
Filed: 1996-04-15
Granted: 2007-06-06
Abstract: An apparatus (10) for loading containers into basket-style bottom-loading carriers (3) has a container infeed mechanism; a carrier infeed supplier (30); a carrier feeder mechanism (50) for removing carriers from the carrier infeed supplier; a carrier timer-transport assembly (60 or 260) for receiving carriers (3) from the carrier infeed supplier and initiating transport of the carriers in synchronous parallel motion above the containers; a gripper (82) assembly for opening the carriers (3); a declination belt assembly (90) forming a pathway for receiving transversely extending bottom panels of said carriers and transporting said carriers downwardly over the groupings of containers; a seating assembly (120) for engaging tops of handles of carriers such that as the seating members rotate the bottommost seating member engages the respective tops of the handles of the carriers; and bottom-panel closure mechanisms (130, 140, 182) for placing the bottom panels together in locking relationship with respect to one another.
Patent JP-3248917-B2 (JP)
IPC: C07D211/70
Filed: 1997-02-27
Granted: 2002-01-21
Abstract: The present invention relates to the use of compounds of general formula wherein R1 is hydrogen, halogen, lower alkyl or lower alkoxy; R2 is hydrogen; R3 is hydrogen, amino, ureido, lower alkylcarbonyl, lower alkyl-sulfonylamino, lower alkylcarbamoyl, carbamoyl, lower alkyloxycarbamoyl, lower alkylamino or R2 and R3 taken together are -(CH2)m-X is methylene, hydroxymethylene, lower alkoxymethylene or carbonyl, n is 0, 1 or 2 and m is 3 or 4 as well as pharmaceutically acceptable salts for the control or treatment of diseases which represent therapeutic indications for NMDA receptor subtype specific blockers.
Patent JP-3967380-B2 (JP)
IPC: F23G5/16
Filed: 1996-05-07
Granted: 2007-08-29
Abstract: In an incineration plant, especially for incinerating waste, of the kind comprising: a) an incineration grate (2) adapted to convey the material being incinerated in the forward direction; and b) an after-treatment (5) for processing the solid products of combustion and possible incombusted parts of said material leaving said incineration grate (2), the main novel feature is c) an active conveyor (3), the conveying direction of which runs transversely to the direction of conveying of said incineration grate (2), adapted to convey said solid products of combustion and possible incombusted parts from said incineration grate (2) directly to the after-treatment unit (5), the width of said conveyor (3) preferably being substantially less than the width of said incineration grate (2).
Patent JP-4380801-B2 (JP)
IPC: C07C67/08
Filed: 1998-03-19
Granted: 2009-12-09
Abstract: This invention concerns a silylated porous microcomposite comprising a perfluorinated ion-exchange polymer entrapped within and highly dispersed throughout a network of inorganic oxide wherein the network and optionally the polymer have been modified with a silylating agent. These silylated microcomposites can be used in heterogeneous catalyst compositions for various chemical processes, such as in esterifications and acylations.
Patent PL-149238-B2 (PL)
Title: Method of obtaining phenyloxyalkanoltriazole compounds
IPC: C07D301/14
Filed: 1987-03-02
Abstract: Compounds of the formula <IMAGE>  in which X represents hydrogen, fluorine, chlorine, bromine, C1-C3-alkyl, C1-C3-alkoxy, trifluoromethyl, phenyl or phenoxy, m is an integer from 1 to 3, it being possible for the individual atoms or groups to be identical or different, if m is greater than 1, and n denotes an integer from 2 to 6, are prepared by reaction of alkene oxides of the formula <IMAGE> with triazole.
Patent ES-2245603-B2 (ES)
Inventor: ALONSO ALONSO RICARDO
IPC: A61K31/357
Filed: 2004-06-25
Granted: 2006-07-01
Abstract: The invention relates to the synthesis of polyoxygenated nitrogen systems, comprising reactions between enamines of 1,3-dioxan-5-ones and nitroolefins. More specifically, the invention relates to the reaction between enamines having formula II which are derived from 1,3-dioxan-5-ones I and nitroolefins having formula III. In this way, novel polyoxygenated nitrogen systems are generated having formula IV and V, which, as they are or following simple transformations, constitute synthetic intermediates and/or analogues of different systems of proven biological/pharmacological interest, such as certain antibiotics, or tetrodotoxin, pancratistatin or the analogues thereof. The aforementioned reactions involve the use of enamines II in Michael-type addition reactions and in direct annealing processes with double acceptor systems at relative positions 1, 3. Said N acceptors include nitroolefins III, wherein R = CHO (alphanitroenals). The invention also relates to the preparation thereof, which is based on the oxidation of the corresponding precursor alcohols VII, and the use of same in annealing processes.
Patent AU-2001242294-B2 (AU)
Title: Method and arrangement for checking whether the use of a service is permissible
Inventor: PREHOFER CHRISTIAN
IPC: H04L47/80
Filed: 2001-03-07
Granted: 2004-07-22
Abstract: An access control function (ZF) which checks a requested use (NU) of a service (DI) by considering an available capacity Cv which is detected by considering the entire transmission capacity (G) and is available to an access node (ZK) for transmitting traffic flows (VS) to the communications network. The service is carried out in at least one communications network (KN) that is provided with an entire transmission capacity (G). The access node (ZK) is allocated to the access control function (ZF) which checks the requested use (NU) of the service (DI).
Patent AU-2001253899-B2 (AU)
Title: Method and apparatus for suturing
Inventor: OREN RAN
IPC: A61B17/06
Filed: 2001-04-18
Granted: 2005-08-18
Abstract: The present invention provides new and useful devices and techniques for use in suturing. These devices and techniques are particularly useful in laparoscopic, arthroscopic, and/or open surgical procedures. A method according to the present invention is characterised by releasably coupling a suture to a suture device, causing the tip of the suture device and a portion of the suture to penetrate a tissue, and releasing the suture from the suture device, so the suture may be drawn through the tissue for completion of a suturing procedure. One type of suturing device (100) according to the invention is characterised by a handle (102) with an elongated shaft (104) with a sharpened tip (106) configured to hold a suture at a selected point on the suture. Another type of device according to the principles of the invention is characterised by the new and useful structures and techniques for loading the suture into the device, According to still another aspect of the present invention, different shaped suture tips are provided for the selection of the most effective tip shape for a given application. A suturing device according to the present invention may also be configured for use with a needle point swedged to a suture. Yet another type of suturing device according to the principles of the present invention included a tissue support structure disposed adjacent the sharpened tip, which may move relative to the sharpened tip to facilitate penetration of the tip through a tissue.
Patent AU-2001258931-B2 (AU)
Title: Floor-treating machine
Inventor: VLIET JOHANNES PETRUS VAN
IPC: B24B7/18
Filed: 2001-05-17
Granted: 2005-10-13
Abstract: Disclosed is a floor-treating machine having a frame with actuating means. A housing is attached to the frame such that it can rotate about a substantially vertical axis. At least three heads are mounted in the housing and each can rotate about a substantially vertical axis. The heads are provided on their bottom surface with treating means and/or coupling means for treating means to be coupled to. A shaft of the motor is concentric with respect to the vertical axis of the frame. The shaft is in driving interaction with the housing and the heads by means of respective transmissions. The transmission for driving the housing includes an auxiliary shaft that runs parallel to and at a distance from the axis of the frame. The auxiliary shaft is connected to the motor shaft via a first auxiliary transmission and to the housing via a second auxiliary transmission.
Patent AU-2002218899-B2 (AU)
Title: System and method for judging boundary lines
Inventor: HARMATH MIKLOS
IPC: G06T7/00
Filed: 2001-12-20
Granted: 2006-06-01
Abstract: There is provided a new and useful system for judging boundary lines on a court in sporting games, for determining whether a ball in play bounces in or out of court. The system comprises at least one camera to capture as frames movement of the ball and a frame grabber associated with each of the cameras to process the frames. An image processing system is configured to receive the digitized frame from the frame grabbers and to process the digitized frame to determine whether the ball is in or out of court and to generate a signal if the ball is out of court. There is an output device coupled to the image processing system to receive the signal and alert the players.
Patent AU-2002305810-B2 (AU)
Title: Method and apparatus for the concentration of fluid-borne pathogens
Inventor: BROWN RICHARD I
IPC: C12N1/02
Filed: 2002-06-04
Granted: 2007-05-17
Abstract: Methods and apparatus for concentrating and recovering pathogens from a fluid other than blood are disclosed. The method includes concentrating the pathogens contained in the fluid by continuously feeding the fluid through one or more flexible chamber(s) and subjecting the chamber(s) to centrifugal forces. The concentrated pathogens may be re-suspended by shaking the chamber(s).